<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-12T20:47:11Z</responseDate>
  <request identifier="oai:figshare.com:article/34040289" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34040289</identifier>
        <datestamp>2026-10-01T06:09:50Z</datestamp>
        <setSpec>category_4</setSpec>
        <setSpec>category_7</setSpec>
        <setSpec>category_12</setSpec>
        <setSpec>category_14</setSpec>
        <setSpec>category_16</setSpec>
        <setSpec>category_873</setSpec>
        <setSpec>category_734</setSpec>
        <setSpec>category_62</setSpec>
        <setSpec>category_64</setSpec>
        <setSpec>portal_81</setSpec>
        <setSpec>item_type_6</setSpec>
        <setSpec>month_year_10_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Additional file 1 of MHY@MO@PPP inhibits ferroptosis positive feedback and delays the acute kidney injury-to-chronic kidney disease transition by remodeling the Fe2+-mTORC1-GPX4 axis</dc:title>
          <dc:creator>Chenhao Li (822769)</dc:creator>
          <dc:creator>Chao Zhang (51048)</dc:creator>
          <dc:creator>Chuanqi Zhang (1639483)</dc:creator>
          <dc:creator>Shiyu Duan (15310003)</dc:creator>
          <dc:creator>Jiali Zhang (31748)</dc:creator>
          <dc:creator>Hongyue Wang (2009332)</dc:creator>
          <dc:subject>Biochemistry</dc:subject>
          <dc:subject>Medicine</dc:subject>
          <dc:subject>Cell Biology</dc:subject>
          <dc:subject>Molecular Biology</dc:subject>
          <dc:subject>Physiology</dc:subject>
          <dc:subject>Chemical Sciences not elsewhere classified</dc:subject>
          <dc:subject>Biological Sciences not elsewhere classified</dc:subject>
          <dc:subject>Marine Biology</dc:subject>
          <dc:subject>Cancer</dc:subject>
          <dc:subject>Ferroptosis</dc:subject>
          <dc:subject>Acute kidney injury-to-chronic kidney disease transition</dc:subject>
          <dc:subject>Mechanistic target of rapamycin complex 1 (mTORC1)</dc:subject>
          <dc:subject>Glutathione peroxidase 4 (GPX4)</dc:subject>
          <dc:subject>Molybdenum Oxide Nanozyme</dc:subject>
          <dc:subject>Fe2+-mTORC1-GPX4 Axis</dc:subject>
          <dc:description>Supplementary Material 1: Figure S1. Construction process and physicochemical property analysis of MoOx nanozymes and protein-environment stability of MHY@MO@PPP. Note: (A) Schematic diagram illustrating the construction process of MoOx nanozymes; (B) TEM observation of the overall morphology and dispersion state of MoOx nanozymes, scale bar: 500 nm; (C) DLS analysis of MoOx nanozymes; (D) FT-IR detection of the chemical bond structure and surface functional group characteristics of MoOx nanozymes; (E) XPS analysis of the chemical valence composition of Mo (Mo⁶⁺/Mo⁵⁺) in MoOx nanozymes, used to evaluate oxygen-vacancy structural characteristics; (F) UV-Vis-NIR absorption spectrum detection of the light absorption characteristics of MoOx nanozymes in the visible to NIR-II range; (G) continuous monitoring for 30 days at 4°C to observe the storage dispersibility of the nanozymes; (H) DLS detection of the hydrodynamic size distribution of MHY@MO@PPP after incubation in PBS or PBS+10% FBS; (I) Zeta potential detection of MHY@MO@PPP after incubation in PBS or PBS+10% FBS; (J) DLS monitoring of MHY@MO@PPP hydrodynamic diameter in PBS+10% FBS at 0, 6, 12, and 24 h to evaluate short-term colloidal stability in a protein-containing environment. All experiments were independently repeated three times, and quantitative data are presented as mean ± SD where applicable. Figure S2. Encapsulation and release characteristics of MHY1485 in MHY@MO@PPP nanozyme complex. Note: (A) LC-MS/MS detection of the characteristic peak of MHY1485 in the MHY@MO@PPP nanozyme complex to verify the encapsulation of MHY1485; (B) LC-MS/MS detection of the release behavior of MHY1485 from the MHY@MO@PPP nanozyme complex under different pH conditions; (C) LC-MS/MS detection of the release behavior of MHY1485 from the MHY@MO@PPP nanozyme complex under different H2O2 stimulation conditions; (D) Laser scanning microscopy observation of the uptake of nanomaterials by HK-2 cells; red fluorescence represents Dil, and blue is DAPI nuclear staining (scale bar: 25 μm). Figure S3. Construction and phenotypic analysis of the HK-2 cell ferroptosis model under a high iron environment. Note: (A) JC-1 fluorescence staining detected mitochondrial membrane potential changes in HK-2 cells, bar: 25 μm; (B) DCFH-DA fluorescence probe detected intracellular ROS generation levels in HK-2 cells, bar: 25 μm; (C) Biochemical kit detected intracellular MDA content in HK-2 cells; (D) Biochemical kit detected intracellular GSH content in HK-2 cells; (E) CCK-8 assay detected changes in HK-2 cell viability; (F) IF staining combined with laser confocal microscopy detected the expression and distribution of Fibronectin protein in HK-2 cells, bar: 25 μm. Cell experiments were repeated three times. * indicates comparison between two groups, p &lt; 0.05, **p &lt; 0.01, ***p &lt; 0.001. Figure S4. Analysis of iron homeostasis dysregulation and cell death characteristics in the ferroptosis model. Note: (A-B) FerroOrange fluorescent staining detection of intracellular free iron levels in HK-2 cells (A) and quantitative analysis results (B), bar: 25 μm; (C) Flow cytometry Annexin V/PI staining detection of HK-2 cell death proportion; (D) Quantitative analysis of PI-positive cell distribution in HK-2 cells by flow cytometry. Cell experiments were repeated three times. * indicates comparison between two groups, p &lt; 0.05, ***p &lt; 0.001. Figure S5. Analysis of molecular expression profiles and renal injury markers in the ferroptosis model. Note: (A) Western blot detection of ferroptosis-related proteins (GPX4, ACSL4, FTH1) expression in HK-2 cells; (B) Western blot detection of autophagy-related proteins p-mTOR and LC3II/I expression in HK-2 cells; (C) Western blot detection of oxidative stress-related protein SOD2 expression in HK-2 cells; (D) RT-qPCR detection of mRNA expression of renal tubular injury markers KIM1, NGAL, and CYSC in HK-2 cells; (E) RT-qPCR detection of mRNA expression of fibrosis and EMT-related genes ACTA2, Fn1, and VIMENTIN in HK-2 cells. Cellular experiments were repeated three times. * indicates comparison between two groups, p &lt; 0.05, **p &lt; 0.01, ***p &lt; 0.001, ****p &lt; 0.0001. Figure S6. Effects of MHY@MO@PPP nanocomposites on iron ion homeostasis and ferroptosis in cells. Note: (A-B) FerroOrange detection of Fe2+ levels in HK-2 cells, bar: 25 μm; (C-D) Annexin V/PI flow cytometry detection of Annexin V/PI-positive cell death proportion. Cell experiments were repeated three times. Comparisons were analyzed by one-way ANOVA followed by Tukey's post hoc test. *p &lt; 0.05, **p &lt; 0.01, ***p &lt; 0.001. Figure S7. Detection of cellular Fe2+ load, death-related phenotypes, and renal injury/fibrosis markers after intervention of the Fe2+-mTORC1-GPX4 axis. Note: (A-B) FerroOrange detection of Fe2+ levels in HK-2 cells, scale bar: 25 μm; (C-D) Annexin V/PI flow cytometry detection of death-related Annexin V/PI-positive cells; (E) RT-qPCR detection of renal injury markers KIM1, NGAL, and CYSC; (F) RT-qPCR detection of fibrosis/EMT markers ACTA2, Fn1, and VIMENTIN. Cell experiments were repeated three times. * indicates comparison between two groups, p &lt; 0.05, **p &lt; 0.01, ***p &lt; 0.001.</dc:description>
          <dc:date>2026-08-20T05:00:00Z</dc:date>
          <dc:type>Text</dc:type>
          <dc:type>Journal contribution</dc:type>
          <dc:identifier>10.6084/m9.figshare.34040289.v1</dc:identifier>
          <dc:relation>https://figshare.com/articles/journal_contribution/Additional_file_1_of_MHY_MO_PPP_inhibits_ferroptosis_positive_feedback_and_delays_the_acute_kidney_injury-to-chronic_kidney_disease_transition_by_remodeling_the_Fe2_-mTORC1-GPX4_axis/34040289</dc:relation>
          <dc:rights>CC BY</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
